hepatitis_c_hero_w251.gif

ERLOCIP 150 MG:
Erlocip tablets consist of active ingredients known as Erlotinib, that is considered as quinazoline derivative and anti-cancer agents that responses as a protein kinase prohibitors for EGFR related to tyrosine kinase. Erlocip is majorly used in the treatment of non-small cell lung cancer and pancreatic carcinoma and also involved to treat various cancers. Erlocip is especially aimed the epidermal growth factor receptor tyrosine kinase.

PRODUCT DETAILS:
Trade name : Erlocip
Active ingredient : Erlotinib
Strength : 150mg
Manufactured by : Cipla
Pack : 30 tablets in a container

URL

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>